The Saudi Arabia Telemedicine market was estimated at USD 531 million in 2015 and is poised to reach USD 1,006 million by 2020, at a CAGR of 13.7% over the next five years. The largest segments of the telemedicine market are Telepathology, Teleradiology, Teledermatology and Telepsychology. Saudi Arabia Telemedicine market can be segmented on the type of telemedicine method being used. These mainly include Telehospitals & Clinics, Telehomes and Pre-Hospitals. Telehospitals is the largest segment among the three. It accounts for nearly US$ 255 million in the year 2015 and is poised to reach US$ 473 million by 2020. The CAGR during this period of forecast is 13.2%. However, Pre-hospitals is the fastest growing segment. It is growing at a rate of 16.2%. Drivers Healthcare costs rising faster than inflation have been a major driver for health care reform. Such a rise in health care costs have raised concerns among the public and private sector. The primary driver of rising healthcare costs in Saudi can be attributed to increased utilization, which includes growing consumer demand, innovative and new techniques, lifestyle factors, etc. Furthermore, it can also be due to cost-shifting from government programs to private payers. Low reimbursement rates have increased cost-shifting burden on hospitals and doctors, who in turn charge much higher rates for the same facilities to private payers, which ultimately affects health insurance rates Restraints Expensive equipment is the biggest barrier in this sector. According to a survey by WHO in Saudi, a barrier of perceived high costs was reported. 60% of respondents considered this as a barrier to the implementation of telemedicine solutions. What the report offers The report identifies the situation of Telemedicine in Saudi Arabia and predicts the growth of the market. The Report also talks about market dynamics, drivers, restraints, trends, opportunities, industrial policies, opportunities, competitive intelligence, investment analysis, etc.
Request a sample report @ https://www.wiseguyreports.com/sample-request/543726-market-entry-telemedicine-industry-2016-2021-docx
Key points in table of content
1.1 MARKET DEFINITION
1.2 BASE CURRENCY
1.3 REVIEW & FORECAST PERIOD YEARS
1.4 REPORT DESCRIPTION
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. KEY INFERENCES
4.1 WHAT IS THE SIZE OF SPEND IN PRIVATE HEALTHCARE?
4.2 WHAT IS THE AVERAGE SPENDING PER CAPITA ON CONSULTATIONS IN SAUDI ARABIA?
4.3 WHAT IS THE AVERAGE SPENDING PER CAPITA ON CONSULTATIONS COVERED BY INSURANCE COMPANIES’ VS CASH CUSTOMERS?
4.4 HOW MANY PATIENTS VISITED HOSPITALS FOR INITIAL CONSULTATIONS, SECOND OPINION AND TRIVIAL FOLLOW UPS IN 2014 AND PROJECTIONS OF GROWTH?
4.5 HOW MANY DOCTORS IN SAUDI ARABIA ARE PROVIDING MEDICAL CONSULTATIONS AND ADVICE ON WHATSAPP, TWITTER AND FACEBOOK?
4.6 WHO ARE THE TOP TELEMEDICINE PROVIDERS IN THE MIDDLE EAST AND SAUDI?
4.7 HOW MANY USERS IN SAUDI ARE ON IPHONE VS ANDROID WHO ARE DOWNLOADING HEALTH APPS?
4.8 WHAT ARE THE BARRIERS FOR DOCTORS TO ADOPT TELEMEDICINE? WHAT ARE THE BARRIERS FOR USERS?
Complete report details @ https://www.wiseguyreports.com/reports/543726-market-entry-telemedicine-industry-2016-2021-docx
5. MARKET OVERVIEW & INDUSTRY TRENDS
5.1 CURRENT MARKET SCENARIO
5.2 APPLICATIONS OF TELEMEDICINE
5.3 TECHNOLOGY OVERVIEW
5.3.1 TECHNOLOGICAL PROPOSITIONS
220.127.116.11 REAL-TIME INTERACTION SERVICES
18.104.22.168 REMOTE MONITORING
5.4 TELEMEDICINE BUSINESS MODELS
5.4.1 MOBILE HEALTH (MHEALTH)
5.4.2 HEALTH KIOSKS
5.4.3 REMOTE HIRING
5.4.4 SPECIALISTS STAY PUT
5.4.5 REMOTE SPECIALISTS
5.5 NEW DEVELOPMENTS
5.6 INDUSTRY VALUE CHAIN ANALYSIS
5.7 PORTERS FIVE FORCE ANALYSIS
5.7.1 BARGAINING POWER OF SUPPLIERS
5.7.2 BARGAINING POWER OF CONSUMERS
5.7.3 THREAT OF NEW ENTRANTS
5.7.4 THREAT OF SUBSTITUTE PRODUCTS & SERVICES
5.7.5 COMPETITIVE RIVALRY WITHIN THE INDUSTRY
6. DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS (DROC)
6.1 MARKET DRIVERS
6.1.1 RISING HEALTHCARE EXPENDITURE
6.1.2 RAPID TECHNOLOGICAL ADVANCES BOOSTING THE TELEMEDICINE MARKET GROWTH
6.1.3 RISING PREVALENCE OF CHRONIC DISEASES
6.2 MARKET RESTRAINTS
6.2.1 EXPENSIVE TECHNOLOGIES
6.2.2 LACK OF PROPER PATIENT AWARENESS
7. SOCIO ECONOMIC INDICATORS
7.1 CONSUMER SENTIMENTS AND THE STATE OF THE ECONOMY
7.2 ECONOMIC STABILITY
7.3. POLITICAL AND SOCIAL STABILITY
8. MARKET ENTRY PARAMETERS
8.1 INDUSTRIAL POLICIES
8.2 GOVERNMENT REGULATIONS
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)